fda tirzepatide compounding warning 2024 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Tirzepatide and Macular Degeneration: Current

Metabolic pathways promoting cancer cell survival and growth

Accepting unwanted experiences can alleviate diabetes distress, which stems from the daily burdens of self-care

I dont, for instance, want to blow my drug budget prescribing edoxaban just because some grubby deal has been done by the DOH

Treatments that mimic GLP-1 can assist with type 2 diabetes and weight management, but consulting with a healthcare provider is essential before starting

van Kaam, MD, PhD, neonatologist, Emma Childrens Hospital, Amsterdam University Medical Centers, location University of Amsterdam, Department of Neonatology, Amsterdam Reproduction & Development, Amsterdam, the Netherlands